pharmaceuticals

Bristol-Myers Squibb & Co (NYSE: BMY) announced its ambitious plan to double the number of treatments undergoing clinical trials in the next 18 months, focusing primarily on targeted protein degradation and cell therapies.  The pharmaceutical giant currently has six candidates in...

Avalo Therapeutics Inc (NASDAQ: AVTX) shares are gaining Wednesday morning on heavy volume, with a session volume of 183.69 million shares traded as compared to the trailing 100-day volume of 10.65 million shares, as per data from Benzinga Pro. In an SEC filing, the company is...

The convergence of artificial intelligence (AI) with the biotech and pharmaceutical sectors is ushering in a new era of innovation. AI is catalyzing transformations from drug discovery to patient care. For investors keen on capturing this intersection's potential, several publicly traded...

Last week, The European Commission authorizing Comirnaty, a third version of the updated COVID-19 vaccine from Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) to be used in EU countries' vaccination campaigns this autumn to combat yet another Covid-19 variant. But...

The chart explores the capital intensity of cannabis compared to four other industries thought to be likely suitors for cannabis companies upon federal legalization: Tobacco, Alcoholic Beverages, Pharmaceuticals, and Consumer Products. In the chart, the cannabis group comprises the nine MSOs with...

Investors are on the hunt for undervalued, underfollowed and emerging stocks, and retail traders have countless methods at their disposal to uncover new information. For some, this may be overwhelming. Benzinga’s Stock Whisper Index uses a combination of proprietary data and pattern...

Key Takeaways: Clover Biopharmaceuticals posted a surge in first-half earnings after a $384 million grant for Covid vaccine development was belatedly folded into its accounts The company has turned its attention to flu vaccines after being hit by waning demand in the crowded Covid market By Molly...

Earlier today, Biogen Inc (NASDAQ: BIIB) agreed to acquire Reata Pharmaceuticals Inc (NASDAQ: RETA) for $172.50 per share in cash, reflecting an enterprise value of approximately $7.3 billion. William Blair analysts Myles Minter, Sarah Schram and Tiffany Marchell...

Shares of Amylyx Pharmaceuticals Inc (NASDAQ: AMLX) jumped in early trading on Monday, after remaining broadly flat last week. Investor concerns around the possible failure of the ongoing Phase III PHOENIX study appear to be “overdone,” according to Goldman Sachs. The Amylyx...

Since launching the Mark Cuban Cost Plus Drug Company in 2022, entrepreneur and NBA team owner Mark Cuban has been on a mission to lower the cost of medicines for consumers. What Happened: Cuban started by tackling the market for generic drugs first, then over time began partnering with...

U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining over 100 points on Wednesday. The Dow traded up 0.25% to 34,347.43 while the NASDAQ rose 1.15% to 13,918.96. The S&P 500 also rose, gaining 0.74% to 4,472.16. These are the top stocks that gained the attention of...

U.S. stocks traded higher toward the end of trading, with the Dow Jones surging more than 300 points on Tuesday. The Dow traded up 0.93% to 34,261.42 while the NASDAQ rose 0.55% to 13,760.70. The S&P 500 also rose, gaining 0.67% to 4,439.26. These are the top stocks that gained the attention of...

U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dropping over 100 points on Thursday. The Dow traded down 1.07 to 33,922.26 while the NASDAQ fell 0.82% to 13,679.04. The S&P 500 also fell, dropping 0.79% to 4,411.59. These are the top stocks that gained the...

U.S. stocks traded mostly lower toward the end of trading, with the Dow Jones dropping around 120 points on Wednesday. The Dow traded down nearly 0.4% to 34,288.64 while the NASDAQ fell 0.18% to 13,791.65. The S&P 500 also fell, dropping 0.2% to 4,446.82. The minutes of the Federal Open Market...

U.S. stocks traded mixed at the closing bell today, with the Dow Jones Industrial Average gaining more than 250 points, up 0.8% to 34,122.42 The NASDAQ, however, was unchanged at 13,591.33, while the S&P 500 rose 0.45% to 4,396.44. These are the top stocks that gained the attention of retail...